UPM Biomedicals enters the Switzerland Innovation Park Basel Area site Main Campus, Europe’s top life sciences hub

(UPM, Helsinki, 11 May 2023 at 10:00 EEST) – UPM Biomedicals is pleased to have established Basel, Switzerland, as the new bridgehead of introducing high quality nanofibrillar cellulose to life science and medical applications. UPM Biomedicals became a member of the Switzerland Innovation Park Basel Area resident community on 10 May and plans to open a cell lab in the premises later this year. “Entering Basel is a milestone for UPM as a leader in sustainable biomaterial development for life science and clinical use. With location in the heart of European pharma, we can easily collaborate